Search
News
Perrigo Q2 2026 earnings: Core sales softness weighs on margins
Perrigo (PRGO) reported fiscal Q2 2026 net sales of $1.023 billion, down 3.2% year over year. Core adjusted EPS fell 20.7% to $0.46, while Core adjusted operating margin narrowed 160 basis points to 13.0% as lower volumes, production under-absorption and unfavorable mix outweighed cost savings. Infant Formula improved and the Dermacosmetics divestiture gain lifted reported earnings, but underlying profitability declined. Perrigo reaffirmed its full-year outlook and expects stronger sequential performance in the second half.
TradingKey
Wed, Aug 5
Choice Hotels Q2 2026 earnings: Room growth lifts adjusted EBITDA
Choice Hotels International reported Q2 2026 revenue of $441 million, up about 3% year over year, while diluted EPS fell to $1.41 from $1.75. Adjusted EBITDA rose 6% to $175 million as U.S. RevPAR increased 1.3% and global net rooms expanded 2.6%. GAAP net income declined 21% to $64 million, mainly because of a larger reimbursable deficit tied to franchisee tools and guest-delivery investments, along with SG&A timing and higher depreciation and amortization. The company also improved its 2026 RevPAR, royalty-rate, and net-room-growth outlooks.
TradingKey
Wed, Aug 5
Zimmer Biomet Q2 2026 Earnings: Revenue Growth Supports Higher Guidance
Zimmer Biomet’s Q2 2026 net sales rose 4.8% to $2.177 billion, while diluted EPS increased 33.8% to $1.03 and adjusted EPS held at $2.07. GAAP profit benefited from lower acquisition-related costs and a lower tax rate, but adjusted operating margin fell to 25.7% from 27.8%. Technology and Data led product growth, while Knees were nearly flat. Operating cash flow reached $447.9 million, and the company raised its fiscal 2026 guidance, with organic constant-currency revenue growth now projected at 2.25% to 3.25%.TradingKey
Wed, Aug 5
BorgWarner Q2 2026 Earnings: Margin Expansion Offsets Organic Sales Decline
BorgWarner’s Q2 2026 net sales rose 0.3% year over year to $3.648 billion, while organic sales fell 1.2% as lower industry production and weaker Battery Energy Systems sales offset currency support. GAAP diluted EPS increased 30.1% to $1.34, and adjusted EPS rose 17.4% to $1.42. Adjusted operating margin expanded 100 basis points to 11.3%, supported by cost controls, while free cash flow was $492 million. The company raised full-year adjusted EPS guidance to $5.05-$5.30 and maintained its sales, margin, and cash flow outlooks.
TradingKey
Wed, Aug 5
Elanco Q2 2026 earnings: Innovation demand lifts revenue and margins
Elanco Animal Health’s Q2 2026 revenue increased 10% to $1.368 billion, with organic constant-currency growth of 8%, while diluted GAAP EPS rose to $0.11 from $0.02. Adjusted EBITDA advanced 21% to $288 million and margin expanded to 21.2%, supported by U.S. Pet Health mix, pricing, and demand for Zenrelia and Credelio Quattro. Operating cash flow reached $277 million, and net leverage declined to 3.1x. Elanco raised its full-year revenue, adjusted EBITDA, adjusted EPS, innovation revenue, and year-end leverage targets.
TradingKey
Wed, Aug 5
Taboola Q2 2026 Earnings: Ex-TAC Profit Growth Outpaces Revenue
Taboola’s Q2 2026 revenue rose 2.4% to $476.8 million, while diluted GAAP EPS improved to $0.01 from a $0.01 loss. Ex-TAC gross profit increased 11.8% to $192.4 million and adjusted EBITDA climbed 22.8% to $55.5 million, with its margin expanding to 28.8%. However, operating cash flow fell to $31.3 million and free cash flow nearly halved to $17.3 million. The quarter showed better adjusted profitability and a return to GAAP net income, but weaker cash conversion remains an important issue for investors to monitor.
TradingKey
Wed, Aug 5
VPG Fiscal Q2 2026 Earnings: Revenue Growth Meets Currency-Driven Profit Pressure
Vishay Precision Group (VPG) reported fiscal Q2 2026 revenue of $83.9 million, up 11.7% year over year, while diluted EPS fell to a $0.13 loss from $0.02 in earnings. Gross margin narrowed to 38.6%, and adjusted EBITDA declined to $5.5 million as unfavorable foreign exchange, delayed steel-system shipments, and product mix weighed on profitability. Bookings reached $95.5 million with a 1.14 book-to-bill ratio. Management expects fiscal 2026 organic revenue growth above its previously outlined 8%–10% range and guided Q3 revenue to $84 million–$89 million.
TradingKey
Wed, Aug 5
Circle Q2 2026 earnings: USDC growth cushions lower reserve yields
Circle’s Q2 2026 earnings included total revenue and reserve income of $701.3 million, up 7% year over year, diluted EPS of $0.18 versus a $4.48 loss, and adjusted EBITDA of $143 million, up 8%. Average USDC in circulation rose 25%, but a 66-basis-point decline in the reserve return rate limited reserve-income growth to 5%. GAAP profit benefited from sharply lower IPO-related stock compensation, while adjusted operating expenses grew 23% and revised guidance includes recognized Arc Token presale revenue.
TradingKey
Wed, Aug 5
Owens Corning Q2 2026 Earnings: Flat Sales Came With Lower Margins
Owens Corning's Q2 2026 earnings showed net sales from continuing operations of $2.756 billion, up less than 1% year over year, while diluted EPS fell 2% to $3.84. Adjusted EBITDA declined 6% to $660 million and margin narrowed to 24% from 26%, as higher cost of sales outweighed modest revenue growth. Operating cash flow improved 22% to $398 million and free cash flow rose 54% to $199 million. Roofing and Insulation sales grew, but EBITDA declined across Roofing, Insulation, and Doors, while Q3 guidance calls for $2.6-$2.7 billion of revenue.
TradingKey
Wed, Aug 5
Dorian LPG Q1 FY2027 earnings: Freight rates lift revenue 123%
Dorian LPG’s Q1 fiscal 2027 revenue rose 123.1% year over year to $187.9 million, while diluted EPS increased to $3.24 from $0.24. Fleet TCE rates climbed 91.1% to $75,926 per available day, supported by geopolitical disruption, stronger spot freight rates and more available days. Net income reached $138.3 million, including a $30.1 million gain on the sale of Cobra; adjusted net income was $107.2 million. Higher charter-in costs and bunker prices were notable offsets, while the expanding VLGC orderbook remains a longer-term risk.
TradingKey
Wed, Aug 5
NW Natural Holdings Q2 2026 earnings: Revenue rose while adjusted EPS stayed flat
NW Natural Holdings reported Q2 2026 revenue of $243.6 million, up 3.1% year over year, and GAAP diluted EPS of $0.01 versus a $0.06 loss a year earlier. Net income improved to $0.6 million, while adjusted EPS remained $0.01 because the prior-year GAAP comparison included transaction and business development costs. SiEnergy profit doubled, but NW Natural and NWN Water earnings fell as O&M, depreciation, and financing costs offset higher utility margins. The company now expects 2026 EPS in the upper half of its $2.95-$3.15 guidance range.
TradingKey
Wed, Aug 5
LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance
LivaNova’s Q2 2026 revenue rose 10.8% to $390.6 million, while GAAP diluted EPS increased to $1.93 from $0.50 and adjusted diluted EPS reached $1.26. Cardiopulmonary and Neuromodulation each posted double-digit reported growth. The company raised constant-currency revenue growth guidance to 8%-9% and adjusted EPS guidance to $4.30-$4.40, but reduced adjusted free cash flow guidance to $140-$160 million. A $95.4 million discrete tax benefit materially boosted GAAP net income, while adjusted operating margin improved to 23.2% from 21.9%.
TradingKey
Wed, Aug 5
NCR Atleos Q2 2026 Earnings: Flat Revenue, Wider Margins
NCR Atleos reported Q2 2026 revenue of $1.103 billion, essentially unchanged year over year, while diluted EPS rose 65% to $0.86. Net income attributable to Atleos increased 67% to $65 million and adjusted EBITDA advanced 25% to $254 million as gross margin expanded to 28.0%. Software and services growth, tariff refunds, productivity, settlement processing and lower vault cash costs offset weaker hardware-related activity, lower crypto transaction demand and elevated fuel and memory costs. Operating cash flow improved to $30 million, though cash conversion remained below quarterly net income.
TradingKey
Wed, Aug 5
LP Building Solutions Q2 2026 earnings: OSB weakness drives profit decline
LP Building Solutions (NYSE: LPX) reported Q2 2026 net sales of $664 million, down $90 million year over year, and diluted EPS of $0.38 versus $0.77. Adjusted EBITDA fell to $79 million as lower OSB prices and volumes, weaker Siding shipments, and inflation outweighed higher Siding pricing. Siding sales declined 4% to $441 million, while OSB sales dropped 27% to $182 million and the segment posted a $21 million adjusted EBITDA loss. LP reaffirmed full-year Siding guidance and expects roughly 5% year-over-year Siding growth in Q3.
TradingKey
Wed, Aug 5
Oaktree Specialty Lending Fiscal Q3 2026 Earnings: Credit Quality Improves as Income Slips
Oaktree Specialty Lending’s fiscal Q3 2026 total investment income fell 7.8% year over year to $69.4 million, while GAAP net investment income eased to $32.5 million and basic and diluted EPS declined to $0.35. Credit quality improved sequentially: non-accrual investments dropped to six from ten and represented 1.8% of debt investments at fair value, versus 2.6% in the prior quarter. NAV was nearly unchanged quarter over quarter at $15.70 per share, while net new investments were negative $27.3 million as repayments and exits exceeded funded activity.
TradingKey
Wed, Aug 5
CLEAR Q2 2026 earnings: Revenue growth drives margin expansion
CLEAR (NYSE: YOU) reported second-quarter 2026 revenue of $277.8 million, up 26.6% year over year, and diluted EPS of $0.49 versus $0.26 a year earlier. Adjusted EBITDA reached $101.1 million, with margin expanding 900 basis points to 36.4%, while free cash flow rose to $189.0 million. Total bookings increased 32.8% to $295.9 million, ahead of revenue growth, and active CLEAR+ membership reached 8.3 million. The company raised its full-year free cash flow floor to $480 million and guided Q3 revenue to $284 million-$287 million.
TradingKey
Wed, Aug 5
Edgewell Fiscal Q3 2026 Earnings: Organic Sales Return to Growth but Margins Contract
Edgewell Personal Care’s fiscal Q3 2026 net sales rose 1.7% to $570.1 million, with organic sales up 1.1% as North America returned to growth. GAAP diluted EPS from continuing operations fell to $0.26 from $0.46, while adjusted EPS held at $0.72. Adjusted gross margin slipped 30 basis points to 44.5%, and adjusted EBITDA declined to $78.9 million. Sun and Skin Care growth offset weaker Wet Shave sales, while Edgewell narrowed full-year adjusted EPS and EBITDA ranges without changing their midpoints and continued to assume a stronger fourth quarter.
TradingKey
Wed, Aug 5
Ecovyst Q2 2026 Earnings: Volume Growth Supports a Raised Outlook
Ecovyst (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42%, while diluted EPS from continuing operations rose to $0.10 from $0.04. Adjusted EBITDA increased 27% to $53.1 million, although its margin fell to 21.2% from 23.8% as sulfur cost pass-throughs lifted revenue and higher manufacturing, inflation, and transportation costs weighed on profitability. The company completed the Calabrian acquisition on June 30 and raised full-year sales and adjusted EBITDA guidance, while net debt leverage increased to 2.0 times.
TradingKey
Wed, Aug 5
Primo Brands Q2 2026 earnings: Retail growth lifts sales and adjusted EBITDA
Primo Brands reported Q2 2026 net sales of $1.796 billion, up 3.8%, while diluted EPS from continuing operations rose to $0.19 from $0.08. Adjusted EBITDA increased 5.0% to $385.0 million and its margin edged up 20 basis points to 21.4%, supported by regional spring water, premium brands, retail channels and Direct Delivery. Gross margin fell 80 basis points as transportation costs and depreciation and amortization increased. The company raised comparable full-year sales growth guidance to 2%-4% but kept adjusted EBITDA and adjusted free cash flow guidance unchanged.
TradingKey
Wed, Aug 5
Pacira Q2 2026 earnings: Revenue rises as adjusted EBITDA declines
Pacira BioSciences’ Q2 2026 revenue rose 6% year over year to $192.4 million, while GAAP diluted EPS improved to $0.12 from a $0.11 loss. However, adjusted EBITDA fell to $48.7 million from $54.3 million as operating expenses increased. EXPAREL sales grew 3% to $147.8 million, with volume gains partly offset by vial mix and broader GPO discounts. Following the iovera° divestiture, Pacira lowered full-year revenue guidance to $735 million-$760 million while maintaining EXPAREL sales and non-GAAP gross-margin guidance.
TradingKey
Wed, Aug 5
Featured Tools
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
Western Digital Shares Plunge 50%: Is It the Best Time to Buy?
Cerebras Cloud Revenue Nearly Quadrupled — But Why Did the Stock Crash 17% on "Confusing" GAAP Results?
